Industry Research Reports
Home > Reports > Service & Software > RNA-Seq- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
RNA-Seq- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Service & Software
Published Date: 2025-02-21
Pages: 140 Pages
Report ld: 4142224
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for RNA-Seq was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
The global RNA-Seq market is experiencing rapid growth due to advancements in sequencing technologies, decreasing costs, and increasing demand for personalized medicine and genomics research. This market holds immense potential for further development and innovation, making it a focal point for companies and researchers in the life sciences industry.
This report aims to provide a comprehensive presentation of the global market for RNA-Seq, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RNA-Seq by region & country, by Type, and by Application.
The RNA-Seq market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA-Seq.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- Illumina
- BGI
- PacBio
- Genewiz
- Macrogen
- LabCorp
- Roche
- Qiagen
- Eurofins
- Novo Gene
- Berry Genomics
- LC Sciences
- Canopy Biosciences
- Macrogen
- Hologic
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- sRNA-Seq
- targeted RNA-Seq
- long-read RNA-Seq
Segment by Application
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RNA-Seq company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of RNA-Seq in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of RNA-Seq in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 RNA-Seq Product Introduction
1.2 Global RNA-Seq Market Size Forecast (2020-2031)
1.3 RNA-Seq Market Trends & Drivers
1.3.1 RNA-Seq Industry Trends
1.3.2 RNA-Seq Market Drivers & Opportunity
1.3.3 RNA-Seq Market Challenges
1.3.4 RNA-Seq Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global RNA-Seq Players Revenue Ranking (2024)
2.2 Global RNA-Seq Revenue by Company (2020-2025)
2.3 Key Companies RNA-Seq Manufacturing Base Distribution and Headquarters
2.4 Key Companies RNA-Seq Product Offered
2.5 Key Companies Time to Begin Mass Production of RNA-Seq
2.6 RNA-Seq Market Competitive Analysis
2.6.1 RNA-Seq Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by RNA-Seq Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Seq as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 sRNA-Seq
3.1.2 targeted RNA-Seq
3.1.3 long-read RNA-Seq
3.2 Global RNA-Seq Sales Value by Type
3.2.1 Global RNA-Seq Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global RNA-Seq Sales Value, by Type (2020-2031)
3.2.3 Global RNA-Seq Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institutes
4.1.2 Hospitals & Clinics
4.1.3 Biotechnology Company
4.1.4 Others
4.2 Global RNA-Seq Sales Value by Application
4.2.1 Global RNA-Seq Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global RNA-Seq Sales Value, by Application (2020-2031)
4.2.3 Global RNA-Seq Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global RNA-Seq Sales Value by Region
5.1.1 Global RNA-Seq Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global RNA-Seq Sales Value by Region (2020-2025)
5.1.3 Global RNA-Seq Sales Value by Region (2026-2031)
5.1.4 Global RNA-Seq Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America RNA-Seq Sales Value, 2020-2031
5.2.2 North America RNA-Seq Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe RNA-Seq Sales Value, 2020-2031
5.3.2 Europe RNA-Seq Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific RNA-Seq Sales Value, 2020-2031
5.4.2 Asia Pacific RNA-Seq Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America RNA-Seq Sales Value, 2020-2031
5.5.2 South America RNA-Seq Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa RNA-Seq Sales Value, 2020-2031
5.6.2 Middle East & Africa RNA-Seq Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions RNA-Seq Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions RNA-Seq Sales Value, 2020-2031
6.3 United States
6.3.1 United States RNA-Seq Sales Value, 2020-2031
6.3.2 United States RNA-Seq Sales Value by Type (%), 2024 VS 2031
6.3.3 United States RNA-Seq Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe RNA-Seq Sales Value, 2020-2031
6.4.2 Europe RNA-Seq Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe RNA-Seq Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China RNA-Seq Sales Value, 2020-2031
6.5.2 China RNA-Seq Sales Value by Type (%), 2024 VS 2031
6.5.3 China RNA-Seq Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan RNA-Seq Sales Value, 2020-2031
6.6.2 Japan RNA-Seq Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan RNA-Seq Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea RNA-Seq Sales Value, 2020-2031
6.7.2 South Korea RNA-Seq Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea RNA-Seq Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia RNA-Seq Sales Value, 2020-2031
6.8.2 Southeast Asia RNA-Seq Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia RNA-Seq Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India RNA-Seq Sales Value, 2020-2031
6.9.2 India RNA-Seq Sales Value by Type (%), 2024 VS 2031
6.9.3 India RNA-Seq Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific RNA-Seq Products, Services and Solutions
7.1.4 Thermo Fisher Scientific RNA-Seq Revenue (US$ Million) & (2020-2025)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Illumina
7.2.1 Illumina Profile
7.2.2 Illumina Main Business
7.2.3 Illumina RNA-Seq Products, Services and Solutions
7.2.4 Illumina RNA-Seq Revenue (US$ Million) & (2020-2025)
7.2.5 Illumina Recent Developments
7.3 BGI
7.3.1 BGI Profile
7.3.2 BGI Main Business
7.3.3 BGI RNA-Seq Products, Services and Solutions
7.3.4 BGI RNA-Seq Revenue (US$ Million) & (2020-2025)
7.3.5 BGI Recent Developments
7.4 PacBio
7.4.1 PacBio Profile
7.4.2 PacBio Main Business
7.4.3 PacBio RNA-Seq Products, Services and Solutions
7.4.4 PacBio RNA-Seq Revenue (US$ Million) & (2020-2025)
7.4.5 PacBio Recent Developments
7.5 Genewiz
7.5.1 Genewiz Profile
7.5.2 Genewiz Main Business
7.5.3 Genewiz RNA-Seq Products, Services and Solutions
7.5.4 Genewiz RNA-Seq Revenue (US$ Million) & (2020-2025)
7.5.5 Genewiz Recent Developments
7.6 Macrogen
7.6.1 Macrogen Profile
7.6.2 Macrogen Main Business
7.6.3 Macrogen RNA-Seq Products, Services and Solutions
7.6.4 Macrogen RNA-Seq Revenue (US$ Million) & (2020-2025)
7.6.5 Macrogen Recent Developments
7.7 LabCorp
7.7.1 LabCorp Profile
7.7.2 LabCorp Main Business
7.7.3 LabCorp RNA-Seq Products, Services and Solutions
7.7.4 LabCorp RNA-Seq Revenue (US$ Million) & (2020-2025)
7.7.5 LabCorp Recent Developments
7.8 Roche
7.8.1 Roche Profile
7.8.2 Roche Main Business
7.8.3 Roche RNA-Seq Products, Services and Solutions
7.8.4 Roche RNA-Seq Revenue (US$ Million) & (2020-2025)
7.8.5 Roche Recent Developments
7.9 Qiagen
7.9.1 Qiagen Profile
7.9.2 Qiagen Main Business
7.9.3 Qiagen RNA-Seq Products, Services and Solutions
7.9.4 Qiagen RNA-Seq Revenue (US$ Million) & (2020-2025)
7.9.5 Qiagen Recent Developments
7.10 Eurofins
7.10.1 Eurofins Profile
7.10.2 Eurofins Main Business
7.10.3 Eurofins RNA-Seq Products, Services and Solutions
7.10.4 Eurofins RNA-Seq Revenue (US$ Million) & (2020-2025)
7.10.5 Eurofins Recent Developments
7.11 Novo Gene
7.11.1 Novo Gene Profile
7.11.2 Novo Gene Main Business
7.11.3 Novo Gene RNA-Seq Products, Services and Solutions
7.11.4 Novo Gene RNA-Seq Revenue (US$ Million) & (2020-2025)
7.11.5 Novo Gene Recent Developments
7.12 Berry Genomics
7.12.1 Berry Genomics Profile
7.12.2 Berry Genomics Main Business
7.12.3 Berry Genomics RNA-Seq Products, Services and Solutions
7.12.4 Berry Genomics RNA-Seq Revenue (US$ Million) & (2020-2025)
7.12.5 Berry Genomics Recent Developments
7.13 LC Sciences
7.13.1 LC Sciences Profile
7.13.2 LC Sciences Main Business
7.13.3 LC Sciences RNA-Seq Products, Services and Solutions
7.13.4 LC Sciences RNA-Seq Revenue (US$ Million) & (2020-2025)
7.13.5 LC Sciences Recent Developments
7.14 Canopy Biosciences
7.14.1 Canopy Biosciences Profile
7.14.2 Canopy Biosciences Main Business
7.14.3 Canopy Biosciences RNA-Seq Products, Services and Solutions
7.14.4 Canopy Biosciences RNA-Seq Revenue (US$ Million) & (2020-2025)
7.14.5 Canopy Biosciences Recent Developments
7.15 Macrogen
7.15.1 Macrogen Profile
7.15.2 Macrogen Main Business
7.15.3 Macrogen RNA-Seq Products, Services and Solutions
7.15.4 Macrogen RNA-Seq Revenue (US$ Million) & (2020-2025)
7.15.5 Macrogen Recent Developments
7.16 Hologic
7.16.1 Hologic Profile
7.16.2 Hologic Main Business
7.16.3 Hologic RNA-Seq Products, Services and Solutions
7.16.4 Hologic RNA-Seq Revenue (US$ Million) & (2020-2025)
7.16.5 Hologic Recent Developments
8 Industry Chain Analysis
8.1 RNA-Seq Industrial Chain
8.2 RNA-Seq Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 RNA-Seq Sales Model
8.5.2 Sales Channel
8.5.3 RNA-Seq Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. RNA-Seq Market Trends
Table 2. RNA-Seq Market Drivers & Opportunity
Table 3. RNA-Seq Market Challenges
Table 4. RNA-Seq Market Restraints
Table 5. Global RNA-Seq Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global RNA-Seq Revenue Market Share by Company (2020-2025)
Table 7. Key Companies RNA-Seq Manufacturing Base Distribution and Headquarters
Table 8. Key Companies RNA-Seq Product Type
Table 9. Key Companies Time to Begin Mass Production of RNA-Seq
Table 10. Global RNA-Seq Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Seq as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global RNA-Seq Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global RNA-Seq Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global RNA-Seq Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global RNA-Seq Sales Market Share in Value by Type (2020-2025)
Table 17. Global RNA-Seq Sales Market Share in Value by Type (2026-2031)
Table 18. Global RNA-Seq Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global RNA-Seq Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global RNA-Seq Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global RNA-Seq Sales Market Share in Value by Application (2020-2025)
Table 22. Global RNA-Seq Sales Market Share in Value by Application (2026-2031)
Table 23. Global RNA-Seq Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global RNA-Seq Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global RNA-Seq Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global RNA-Seq Sales Value by Region (2020-2025) & (%)
Table 27. Global RNA-Seq Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions RNA-Seq Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions RNA-Seq Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions RNA-Seq Sales Value, (2026-2031) & (US$ Million)
Table 31. Thermo Fisher Scientific Basic Information List
Table 32. Thermo Fisher Scientific Description and Business Overview
Table 33. Thermo Fisher Scientific RNA-Seq Products, Services and Solutions
Table 34. Revenue (US$ Million) in RNA-Seq Business of Thermo Fisher Scientific (2020-2025)
Table 35. Thermo Fisher Scientific Recent Developments
Table 36. Illumina Basic Information List
Table 37. Illumina Description and Business Overview
Table 38. Illumina RNA-Seq Products, Services and Solutions
Table 39. Revenue (US$ Million) in RNA-Seq Business of Illumina (2020-2025)
Table 40. Illumina Recent Developments
Table 41. BGI Basic Information List
Table 42. BGI Description and Business Overview
Table 43. BGI RNA-Seq Products, Services and Solutions
Table 44. Revenue (US$ Million) in RNA-Seq Business of BGI (2020-2025)
Table 45. BGI Recent Developments
Table 46. PacBio Basic Information List
Table 47. PacBio Description and Business Overview
Table 48. PacBio RNA-Seq Products, Services and Solutions
Table 49. Revenue (US$ Million) in RNA-Seq Business of PacBio (2020-2025)
Table 50. PacBio Recent Developments
Table 51. Genewiz Basic Information List
Table 52. Genewiz Description and Business Overview
Table 53. Genewiz RNA-Seq Products, Services and Solutions
Table 54. Revenue (US$ Million) in RNA-Seq Business of Genewiz (2020-2025)
Table 55. Genewiz Recent Developments
Table 56. Macrogen Basic Information List
Table 57. Macrogen Description and Business Overview
Table 58. Macrogen RNA-Seq Products, Services and Solutions
Table 59. Revenue (US$ Million) in RNA-Seq Business of Macrogen (2020-2025)
Table 60. Macrogen Recent Developments
Table 61. LabCorp Basic Information List
Table 62. LabCorp Description and Business Overview
Table 63. LabCorp RNA-Seq Products, Services and Solutions
Table 64. Revenue (US$ Million) in RNA-Seq Business of LabCorp (2020-2025)
Table 65. LabCorp Recent Developments
Table 66. Roche Basic Information List
Table 67. Roche Description and Business Overview
Table 68. Roche RNA-Seq Products, Services and Solutions
Table 69. Revenue (US$ Million) in RNA-Seq Business of Roche (2020-2025)
Table 70. Roche Recent Developments
Table 71. Qiagen Basic Information List
Table 72. Qiagen Description and Business Overview
Table 73. Qiagen RNA-Seq Products, Services and Solutions
Table 74. Revenue (US$ Million) in RNA-Seq Business of Qiagen (2020-2025)
Table 75. Qiagen Recent Developments
Table 76. Eurofins Basic Information List
Table 77. Eurofins Description and Business Overview
Table 78. Eurofins RNA-Seq Products, Services and Solutions
Table 79. Revenue (US$ Million) in RNA-Seq Business of Eurofins (2020-2025)
Table 80. Eurofins Recent Developments
Table 81. Novo Gene Basic Information List
Table 82. Novo Gene Description and Business Overview
Table 83. Novo Gene RNA-Seq Products, Services and Solutions
Table 84. Revenue (US$ Million) in RNA-Seq Business of Novo Gene (2020-2025)
Table 85. Novo Gene Recent Developments
Table 86. Berry Genomics Basic Information List
Table 87. Berry Genomics Description and Business Overview
Table 88. Berry Genomics RNA-Seq Products, Services and Solutions
Table 89. Revenue (US$ Million) in RNA-Seq Business of Berry Genomics (2020-2025)
Table 90. Berry Genomics Recent Developments
Table 91. LC Sciences Basic Information List
Table 92. LC Sciences Description and Business Overview
Table 93. LC Sciences RNA-Seq Products, Services and Solutions
Table 94. Revenue (US$ Million) in RNA-Seq Business of LC Sciences (2020-2025)
Table 95. LC Sciences Recent Developments
Table 96. Canopy Biosciences Basic Information List
Table 97. Canopy Biosciences Description and Business Overview
Table 98. Canopy Biosciences RNA-Seq Products, Services and Solutions
Table 99. Revenue (US$ Million) in RNA-Seq Business of Canopy Biosciences (2020-2025)
Table 100. Canopy Biosciences Recent Developments
Table 101. Macrogen Basic Information List
Table 102. Macrogen Description and Business Overview
Table 103. Macrogen RNA-Seq Products, Services and Solutions
Table 104. Revenue (US$ Million) in RNA-Seq Business of Macrogen (2020-2025)
Table 105. Macrogen Recent Developments
Table 106. Hologic Basic Information List
Table 107. Hologic Description and Business Overview
Table 108. Hologic RNA-Seq Products, Services and Solutions
Table 109. Revenue (US$ Million) in RNA-Seq Business of Hologic (2020-2025)
Table 110. Hologic Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. RNA-Seq Downstream Customers
Table 114. RNA-Seq Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. RNA-Seq Product Picture
Figure 2. Global RNA-Seq Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global RNA-Seq Sales Value (2020-2031) & (US$ Million)
Figure 4. RNA-Seq Report Years Considered
Figure 5. Global RNA-Seq Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by RNA-Seq Revenue in 2024
Figure 7. RNA-Seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. sRNA-Seq Picture
Figure 9. targeted RNA-Seq Picture
Figure 10. long-read RNA-Seq Picture
Figure 11. Global RNA-Seq Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global RNA-Seq Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Research Institutes
Figure 14. Product Picture of Hospitals & Clinics
Figure 15. Product Picture of Biotechnology Company
Figure 16. Product Picture of Others
Figure 17. Global RNA-Seq Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 18. Global RNA-Seq Sales Value Market Share by Application, 2024 & 2031
Figure 19. North America RNA-Seq Sales Value (2020-2031) & (US$ Million)
Figure 20. North America RNA-Seq Sales Value by Country (%), 2024 VS 2031
Figure 21. Europe RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 22. Europe RNA-Seq Sales Value by Country (%), 2024 VS 2031
Figure 23. Asia Pacific RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 24. Asia Pacific RNA-Seq Sales Value by Region (%), 2024 VS 2031
Figure 25. South America RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 26. South America RNA-Seq Sales Value by Country (%), 2024 VS 2031
Figure 27. Middle East & Africa RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 28. Middle East & Africa RNA-Seq Sales Value by Country (%), 2024 VS 2031
Figure 29. Key Countries/Regions RNA-Seq Sales Value (%), (2020-2031)
Figure 30. United States RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 31. United States RNA-Seq Sales Value by Type (%), 2024 VS 2031
Figure 32. United States RNA-Seq Sales Value by Application (%), 2024 VS 2031
Figure 33. Europe RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 34. Europe RNA-Seq Sales Value by Type (%), 2024 VS 2031
Figure 35. Europe RNA-Seq Sales Value by Application (%), 2024 VS 2031
Figure 36. China RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 37. China RNA-Seq Sales Value by Type (%), 2024 VS 2031
Figure 38. China RNA-Seq Sales Value by Application (%), 2024 VS 2031
Figure 39. Japan RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 40. Japan RNA-Seq Sales Value by Type (%), 2024 VS 2031
Figure 41. Japan RNA-Seq Sales Value by Application (%), 2024 VS 2031
Figure 42. South Korea RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 43. South Korea RNA-Seq Sales Value by Type (%), 2024 VS 2031
Figure 44. South Korea RNA-Seq Sales Value by Application (%), 2024 VS 2031
Figure 45. Southeast Asia RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 46. Southeast Asia RNA-Seq Sales Value by Type (%), 2024 VS 2031
Figure 47. Southeast Asia RNA-Seq Sales Value by Application (%), 2024 VS 2031
Figure 48. India RNA-Seq Sales Value, (2020-2031) & (US$ Million)
Figure 49. India RNA-Seq Sales Value by Type (%), 2024 VS 2031
Figure 50. India RNA-Seq Sales Value by Application (%), 2024 VS 2031
Figure 51. RNA-Seq Industrial Chain
Figure 52. RNA-Seq Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global RNA-Seq market?
The top companies in the global RNA-Seq market are Thermo Fisher Scientific、Illumina、BGI.
Related Reports
RNA-Seq - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for RNA-Seq was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 129
USD 3950.00
(Single User License)
Global RNA-Seq Market Research Report 2026
The global RNA-Seq market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 127
USD 2900.00
(Single User License)
Global RNA-Seq Market Outlook, In‑Depth Analysis & Forecast to 2032
The global RNA-Seq market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-01-10
Pages: 156
USD 4900.00
(Single User License)
Global RNA-Seq Market Outlook, In‑Depth Analysis & Forecast to 2031
The global RNA-Seq market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 153
USD 4900.00
(Single User License)
Global RNA-Seq Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global RNA-Seq market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 103
USD 4250.00
(Single User License)
Global RNA-Seq Market Research Report 2025
The global market for RNA-Seq was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 99
USD 2900.00
(Single User License)
Global RNA-Seq Market Insights, Forecast to 2030
Market Analysis and Insights: Global RNA-Seq Market
Published Date: 2024-04-16
Pages: 119
USD 4900.00
(Single User License)
Global RNA-Seq Market Research Report 2024
The global RNA-Seq market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 99
USD 2900.00
(Single User License)
RNA-Seq - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for RNA-Seq was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 129
USD 3950.00 (Single User License)Global RNA-Seq Market Research Report 2026
The global RNA-Seq market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 127
USD 2900.00 (Single User License)Global RNA-Seq Market Outlook, In‑Depth Analysis & Forecast to 2032
The global RNA-Seq market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-01-10
Pages: 156
USD 4900.00 (Single User License)Global RNA-Seq Market Outlook, In‑Depth Analysis & Forecast to 2031
The global RNA-Seq market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 153
USD 4900.00 (Single User License)Global RNA-Seq Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global RNA-Seq market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 103
USD 4250.00 (Single User License)Global RNA-Seq Market Research Report 2025
The global market for RNA-Seq was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 99
USD 2900.00 (Single User License)Global RNA-Seq Market Insights, Forecast to 2030
Market Analysis and Insights: Global RNA-Seq Market
Published: 2024-04-16
Pages: 119
USD 4900.00 (Single User License)Global RNA-Seq Market Research Report 2024
The global RNA-Seq market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 99
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now